Clinical Trial Results:
Safety and Efficacy of Exenatide Once Weekly Injection versus Metformin, Dipeptidyl
Peptidase-4 Inhibitor, or Thiazolidinedione as Monotherapy in Drug-Naive Patients with Type 2 Diabetes
Summary
|
|
EudraCT number |
2008-000854-11 |
Trial protocol |
HU PL SK ES FR DE IT BE GB |
Global completion date |
09 Jun 2010
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
04 Jan 2019
|
First version publication date |
04 Jan 2019
|
Other versions |
|
Summary report(s) |
GWCH Summary |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.